IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aeolus Pharmaceuticals Inc (AOLS)

CUSIP: 00765G109 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 3 institutional holders

Quarters

Q3 2017Q2 2017Q1 2017Q4 2016Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2017

Intellectus Partners, LLC170
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Intellectus Partners, LLC
170$00.0%GrowthMediumSan Francisco, CA2017-11-14